Skip to main content
. 2020 Apr 27;295(23):7905–7922. doi: 10.1074/jbc.RA119.012517

Figure 2.

Figure 2.

c-Abl–mediated in vitro phosphorylation and characterization of Tau (pTau). Phosphorylation was performed for 4 h, which leads to a mixture of Tau phosphorylated on two to five residues. Characterization of the RP-HPLC purified Tau and the pTau mixtures by LC-MS (A), UPLC (B), and SDS-PAGE (C). D and E, tandem LC/MS/MS of RP-HPLC purified pTau following trypsin digestion and peptides enrichment using a TiO2 resin. The analysis of the phosphopeptides was performed using the Scaffold version 4.0 (Proteome Software), and the number of phosphopeptides detected per phosphorylation site was reported as the spectral count (SP).